ÂÜÀòÂÒÂ×

Daniela Bezdan has a diverse range of work experience in various scientific and research roles. Daniela is currently the Chief Scientific Officer (CSO) at Yuri, a commercial space industry company focused on biotech engineering and precision medicine in space under microgravity. Prior to this, they were a Co-Founder and SAB member at Poppy, the world's first commercially available pathogen sensing and detection network. Daniela has also worked as a Research Associate at the Universitätklinikum Tübingen der Eberhard-Karl-Universität and as a Topical Team member at the European Space Agency (ESA) space omics TT.

In addition, Daniela was the Co-Chair of the NASA GeneLab Microbiome AWG and the Co-Chair of Business Development at ISSOP - International Standards in Space Omics Procedures, a collaborative project between NASA, ESA, and JAXA. Daniela was also involved in space research as a Co-Founder/Advisor at Analogs LLC, a space research company.

Earlier in their career, Daniela served as the Chief Scientific Officer at Bumrungrad International Hospital (BIH), a prestigious private hospital in Asia and Europe. Daniela has also held research positions at Weill Cornell Medicine and the Centre for Genomic Regulation (CRG) where they worked as a Research Associate and Senior Research Scientist respectively.

Overall, Daniela Bezdan's work experience demonstrates their expertise and passion for scientific research, particularly in the fields of biotech engineering, precision medicine, pathogen detection, and space omics.

Daniela Bezdan has an extensive education history in the field of genomics, bioinformatics, and molecular biology. Daniela began their academic journey in 1994 by completing a Technician program at the University of Stuttgart, where they studied Organic Chemistry and Biochemistry. Following this, from 1998 to 1999, they obtained a University Entrance Qualification (BKFH) in Biotechnology from the Hedwig-Dohm-School in Stuttgart.

In 1999, Daniela enrolled at Mannheim University of Applied Science (M.U.A.S) and earned a Bachelor of Applied Science (B.A.Sc.) and a Dipl.-Ing. Biotechnology (FH) degree between 1999 and 2004. Their studies focused on Biotechnology Engineering.

In 2003, they pursued further education at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and successfully completed a Dipl.-Ing. Biotechnology (FH)/Diploma degree in Molecular Biology, Development, and microRNAs in 2004.

Continuing their academic pursuits, Daniela joined the Max-Planck Institute Tuebingen in Tuebingen, Germany, in 2005, where they engaged in a PhD candidate program in Genome Sciences/Genomics. Daniela concluded their doctoral studies in 2010.

After a brief break, Daniela returned to academia in 2014 by pursuing a Master of Science (M.Sc.) degree in Bioinformatic with a focus on Biomathematics, Bioinformatics, and Computational Biology at the Universitat Autònoma de Barcelona (UAB) in Spain. Daniela successfully completed their master's degree in 2015.

Although not mentioned in the provided information, Daniela has an additional certification in GMP (Good Manufacturing Practice). However, the institution and specific details of when and where they obtained this certification are not provided.